/

Empresas

Sh

No verificado

Shorla Oncology

Sobre qué escribimos

FarmacéuticaHigiene alimentariaIndustriaOncologíaSalud

6 Comunicados de prensa

Ver todos los comunicados de prensa

15/07/2025

Industria

Higiene alimentaria

Sanidad

Salud

Farmacéutica

Oncología

Ciencia

Shorla Oncology Announces FDA Orphan Drug Designation for SH-110 to Treat Rare Brain Cancer Using Oral Liquid

Fuente

Shorla Oncology

Editor

1.00

0

29/04/2025

Shorla Oncology Announces FDA Approval of TEPYLUTE® 100mg, First and Only Ready-to-Dilute Multi-Dose Vial of Thiotepa to Treat Breast and Ovarian Cancer and Commercial Launch of TEPYLUTE 15mg and 100mg Vials in the U.S.

Fuente

Shorla Oncology

Editor

1.00

0

04/03/2025

Shorla Oncology Announces Expansion of U.S. Commercial Footprint with Launch of Dedicated Sales Force and Market Access Teams

Fuente

Shorla Oncology

Editor

1.00

0

25/11/2024

Multimedia

Industria

Higiene alimentaria

Farmacéutica

Salud

Oncología

Shorla Oncology Announces FDA Approval of IMKELDI (imatinib) Oral Solution, an Oral Liquid for the Treatment of Certain Forms of Leukemia and Other Cancers

Fuente

Shorla Oncology

Editor

1.00

0

29/10/2024

Shorla Oncology Announces U.S. Food and Drug Administration (FDA) Expanded Approval of JYLAMVO™ (methotrexate), an Oncology and Autoimmune Drug for Pediatric Indications

Fuente

Shorla Oncology

Editor

1.00

0

28/06/2024

Industria

Higiene alimentaria

Sanidad

Salud

Farmacéutica

Oncología

Ciencia

Shorla Oncology Announces FDA Approval for TEPYLUTE, A Novel Formulation to Treat Breast and Ovarian Cancer

Fuente

Shorla Oncology

Editor

1.00

0

Seguidores

0

Compatibilidad

0